avender Aromatherapy in the Treatment of Anxiety And Dpressio
- Conditions
- ANXEITY AND DEORESION.Neurotic, stress-related and somatoform disorders(F00-F99)
- Registration Number
- IRCT2012111711498N1
- Lead Sponsor
- Shahed Univer Sity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 110
The inclusion criteria:Having high anxiety and depression scores of 7 tools HADS,Age over 18 years , Patients with a diagnosis of ischemic heart disease, angina and myocardial infarction,No risk of cardiogenic shock, having very poor medical condition, according to doctors at the hospital, Agree attract physicians to enter patients into the study, no pacemaker, no use of complementary therapies (herbal treatments, traditional and other therapies) in a week, no history of psychiatric disorders or being treated for anxiety and depression, lack of drug abuse, no history of asthma, eczema.
Exclusion criteria included: patient withdrew from the study, grade 3 or 4 heart failure, discharge, or transfer the patient died before the completion of the study, a new stressful situations
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anxiety. Timepoint: Before the experiment, a time period of 2 days, 9 hours after the intervention. Method of measurement: HADS, Hospital Anxiety and Depression questionnaire.;DEPRESSION. Timepoint: Before the experiment, a time period of 2 days, 9 hours after the intervention. Method of measurement: HADS, Hospital Anxiety and Depression questionnaire.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: Before the study, an hour later, 9 hours after the study. Method of measurement: Each patient monitoring devices over.;PULSE. Timepoint: Before the study, an hour later, 9 hours after the study. Method of measurement: Each patient monitoring devices over.